Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: An animal model for CEA-directed tumor immunotherapy
Open Access
- 3 July 1997
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 72 (1) , 197-202
- https://doi.org/10.1002/(sici)1097-0215(19970703)72:1<197::aid-ijc28>3.0.co;2-f
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Use of Epstein-Barr Virus-Transformed B Lymphocyte Cell Lines in a Peptide-Reconstitution AssayJournal of Immunotherapy, 1995
- Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine.Journal of Clinical Investigation, 1995
- Carcinoembryonic Antigen as a Target Cancer Antigen for Radiolabeled Antibodies: Prospects for Cancer Imaging and TherapyTumor Biology, 1995
- Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patientsCancer, 1994
- Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouseCell, 1993
- Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.Proceedings of the National Academy of Sciences, 1992
- Identification and characterization of the familial adenomatous polyposis coli geneCell, 1991
- Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression.Molecular and Cellular Biology, 1990
- Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185Cell, 1986
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986